Recombinant HDL-Like Nanoparticles: A Specific Contrast Agent for MRI of Atherosclerotic Plaques
- 24 November 2004
- journal article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 126 (50), 16316-16317
- https://doi.org/10.1021/ja044911a
Abstract
A new contrast agent for MRI based on recombinant HDL-like nanoparticles has been prepared. It shows a great potential as a contrast agent for atherosclerotic plaques in a relative short time (24 h post-injection) as it is selective for the plaques and is an endogenous molecule. It also can distinguish between different types of plaques as the enhancement obtained is different, depending on plaque composition.This publication has 10 references indexed in Scilit:
- Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary SyndromesJAMA, 2003
- High density lipoproteins (HDLs) and atherosclerosis; the unanswered questionsAtherosclerosis, 2003
- Inflammation in atherosclerosisNature, 2002
- Recombinant lipoproteins: lipoprotein-like lipid particles for drug targetingAdvanced Drug Delivery Reviews, 2001
- AtherosclerosisNature, 2000
- Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and ApplicationsChemical Reviews, 1999
- Mouse Models of AtherosclerosisScience, 1996
- Production and Characterization of a Reconstituted High Density Lipoprotein for Therapeutic ApplicationsVox Sanguinis, 1996
- Digital imaging fluorescence microscopyMethods in Enzymology, 1986
- [33] Reassembly of low-density lipoproteinsMethods in Enzymology, 1986